TNF-α diffuses from the tumor to the pituitary gland; an additional source of TNF-α originates in the pituitary gland as ipilimumab (which is infused into the blood) and targets the CTLA-4 expressed on pituitary cells. The gene discussed is CTLA4; the disease is neoplasm.